JFJoelle N. Friesen

Joelle N. Friesen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joelle N. Friesen has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Initial Pulmonary Nodule Management for the Generalist: A Brief Review

    by Joelle N. Friesen, Cassandra Braun, Ashley Egan


  • Rapid Response Events Prompt Increased Goals of Care Discussions and Code Status Changes

    by Joelle N. Friesen, Erik J. Wanberg, Alexandra Allman, Allison LeMahieu, Kelly Pennington, Alice Gallo de Moraes

    Background: While rapid response teams (RRT) are widely implemented to address clinical deterioration in hospitalized patients, their impact on goals of care (GOC) discussions remains underexplored. Aims: We aimed to evaluate whether RRT activations were associated with subsequent goals of care discussions, code status changes, and clinical outcomes. Methods: We conducted a retrospective single-center review of hospitalized adult patients admitted to medicine services who had RRT activations between January and December 2023. The primary outcome was GOC discussion within 72 h of RRT. GOC discussions were identified through EMR documentation of conversations, code status changes, and ACP notes. Secondary outcomes included code status change, transition to comfort care, and 30- and 90-day mortality. Analyses were adjusted using inverse probability of treatment weighting. Results: 1823 RRTs among 1677 patients were analyzed; 47% of patients were female and 88% identified as white. Those transferred to the ICU had higher odds of goals of care discussions (OR 1.52, P < 0.001), code status change (OR 2.43, P < 0.001), and transition to comfort care (OR 1.47, P = 0.026) compared to those who remained on the floor. ICU transfer was also associated with increased 30- (OR 1.39, P = 0.006) and 90-day mortality (OR 1.30, P = 0.014). Conclusions: ICU transfer following RRT activation is strongly associated with downstream goals of care discussions, changes in code status, comfort-focused care, and higher mortality. This demonstrates the importance of initiating goals of care discussions early and often, regardless of whether clinical decompensation is anticipated.


  • Outcomes in lung transplant recipients on azathioprine compared to mycophenolate

    by David M. Sanborn, Joelle N. Friesen, Hemang Yadav, Cassie C. Kennedy, Mark E. Wylam, Steve G. Peters, John P. Scott, Sahar A. Saddoughi, Kelly M. Pennington


  • Exploring Rapid Response Team Activation Impact in Patients with Cirrhosis with Acute Decompensation

    by Joelle N. Friesen, Mackenzie Maberry, Jody C. Olson, Alice Gallo de Moraes

    Background: Cirrhosis is associated with significant healthcare utilization, yet data about in-hospital decompensations remain sparse. Additionally, the impact of liver transplant candidacy status on resuscitation and outcomes is largely unknown. Aims: We aimed to evaluate the characteristics of resuscitation events for patients with cirrhosis with acute decompensation, analyzing liver transplant candidacy and intensive care unit (ICU) transfer parameters. Methods: Retrospective single-center review of adult patients with liver cirrhosis who had a rapid response team (RRT) activation during hospitalization and no prior liver transplantation. Results: Patients with cirrhosis who were liver transplant candidates were more likely to be younger ( p = .003), have a higher serum total bilirubin ( p = .015), higher INR ( p < .001), and higher MELD 3.0 ( p = .006). There was no significant difference in ICU transfer ( p = .170) after RRT activation. Liver transplant candidates had a lower 30- and 60-day mortality ( p = .008, p = .014) and were less likely to have a code status discussion after decompensation ( p = .001). Lower serum albumin was associated with ICU transfer ( p = .001). Patients who transferred to the ICU were more likely to have a code status discussion within 24 h after RRT ( p = .011) without significant difference in 30- or 60-day mortality ( p = .059, p = .277). Conclusions: Liver transplant candidacy in patients with cirrhosis with acute decompensation is not clearly correlated with ICU transfer. Liver transplant candidates are more likely to be younger, have higher MELD 3.0 scores, less likely to have code status discussed after RRT, and have lower 30- and 60-day mortality rates. Patients who transfer to the ICU are more likely to have a code status discussion without any significant difference in 30- or 60-day mortality.

  • Role of genetic testing in pleuroparenchymal fibroelastosis

    by Joelle Friesen, Ghadah Alrehaili, Jennifer Kemppainen, Sanjay Kalra, Filippo Pinto E Vairo, Teng Moua, Eunhee Yi, Alejandro Ferrer, Mrinal Patnaik, Eva Carmona

    Introduction: There is increasing recognition of the importance of genetic testing in the evaluation of pulmonary fibrosis, particularly since telomere biology disorders (TBD) and surfactant protein gene abnormalities are clinically indistinguishable from cases without known pathogenic gene variants. In this study, we aim to demonstrate the role of genetic testing in pleuroparenchymal fibroelastosis (PPFE) through analysis of 6 cases of PPFE. Methods: 70 patients with premature or familial pulmonary fibrosis were evaluted for PPFE through radiologic and/or histopathologic methods. Flow-FISH testing of peripheral blood analyzed telomere length and an exome-based panel assessed 33 pertinent genes using DNA from whole blood. Results: Among the 70 patients, six patients (8.6%) with PPFE were identified. Five patients were female and median age was 61 years (range 32-70). All PPFE patients had telomere or surfactant protein variants. Five patients (83%) had lymphocyte and granulocyte telomere length less than the 10th percentile. Of these five, four (80%) had a genetic variant in known telomere-related genes. One patient had a heterozygous surfactant protein A2 (SFTPA2) variant. Further data are provided in Table 1. erj;64/suppl_68/PA4292/F1 F1 F1 Conclusions: Evaluating for TBD and surfactant protein gene variants in patients with PPFE can improve understanding of the underlying disease process and contribute to improved diagnosis and management of patients and their relatives.

  • Open Access

    Upper Tract Urothelial Carcinoma Complicated by Skeletal Muscle Metastases

    by Joelle N. Friesen, Bibek Saha, Ashley Hickman, Jian L. Campian

    Upper Tract Urothelial Carcinoma Complicated by Skeletal Muscle Metastases


  • 50-Year-Old Man With Fevers, Cough, and Night Sweats

    by Joelle N. Friesen, Alexandra Allman, Omar Abu Saleh